3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Neurology - Tobacco & Marijuana -

Cigarette Smoking May Accelerate Disability in Those with MS

Neurology • • Tobacco & MarijuanaOct 15, 07

Persons with multiple sclerosis who smoke risk increasing the amount of brain tissue shrinkage, a consequence of MS, and the subsequent severity of their disease, new research conducted at the Buffalo Neuroimaging Analysis Center (BNAC) at the University at Buffalo has shown.

The results are based on magnetic resonance images (MRIs) of smokers and nonsmokers in 368 MS patients treated in UB’s Jacobs Neurological Institute, the university’s Department of Neurology in its School of Medicine and Biomedical Sciences.

Results of the research were presented today (Oct. 13, 2007) at the 23rd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis in Prague, Czech Republic.

“Cigarette smoke has many properties that are toxic to the central nervous system, and cigarette smoking has been linked to higher susceptibility and risk of progressive multiple sclerosis,” said Robert Zivadinov, M.D., Ph.D., UB professor of neurology, director of the BNAC and first author on the study.

“Interactions between cigarette smoking and genetic and immunologic factors may point to mechanisms in disease pathogenesis. No previous studies have investigated differences in MRI characteristics between MS cigarette smokers and MS nonsmokers,” he said.

The study included patients from the three most common forms of MS: 253 had relapsing-remitting MS—acute attacks with full or partial recovery; nine had primary-progressive MS—steady worsening from onset; and 90 had secondary-progressive MS, characterized by occasional attacks and sustained progression. Another 16 participants had experienced their first MS onset.

Patients ranged in age from 35-55 years, and had been living with MS for an average of 13 years. The Expanded Disability Status Scale (EDSS), an average number derived from measures of various functions of the central nervous system based on scales ranging from 0 to 10, was 3.1. The higher the number, the greater the disability.

Within the study cohort, 128 had a history of smoking: 96 were active smokers who had smoked more than 10 cigarettes-per-day in the three months prior to the study start, and 32 were former smokers who had smoked cumulatively for at least 6 months sometime in the past. The remaining 240 participants had no active smoking exposure.

The average smoking duration was 17.6 years and the average number of cigarettes smoked per day was 17. There were no significant differences between smokers and nonsmokers based on age, disease duration, disease course and total lifetime use of disease-modifying drugs.

Analysis and comparison of the MRIs from smokers and nonsmokers showed that the smokers had significantly higher disability scores and lower brain volume than the nonsmokers. There also was a significant relationship between a higher number of packs-per-day smoked and lower volume of the neocortex, the portion of the cerebral cortex that serves as the center of higher mental functions for humans.

There were no significant differences in any of the clinical findings between active and former smokers.

“Smoking appears to influence the severity of MS and to accelerate brain atrophy and the disruption of the blood-brain barrier in MS patients,” said Zivadinov. “MS patients should be counseled to stop smoking, or at least to cut down so they can preserve as much brain function as possible.”

Additional researchers on the study, all from the BNAC or the JNI, were Milena Stosic, M.D., Nadir Abdelrahman, M.D., Barbara E. Teter, Ph.D., Frederick E. Munschauer, M.D., Sara Hussein, Jackie Durfee, Michael G. Dwyer, Jennifer L. Cox, Ph.D., Nima Hani, Fernando Nussenbaum and Bianca Weinstock-Guttman, M.D.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. The School of Medicine and Biomedical Sciences is one of five schools that constitute UB’s Academic Health Center. UB’s more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.


Release Date
10/13/07
Contact
Lois Baker
.(JavaScript must be enabled to view this email address)
716-645-5000 ext 1417



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Large doses of antioxidants may be harmful to neuronal stem cells
  Repairing the cerebral cortex: It can be done
  Quitting smoking has favorable metabolic effects
  UTSW researchers identify a therapeutic strategy that may treat a childhood neurological disorder
  To advance care for patients with brain metastases: Reject five myths
  Study Explains How High Blood Pressure in Middle Age Affects Memory in Old Age
  Study reveals workings of working memory
  Family problems experienced in childhood and adolescence affect brain development
  Researchers find retrieval practice improves memory in severe traumatic brain injury
  Study finds axon regeneration after Schwann cell graft to injured spinal cord
  Recurring memory traces boost long-lasting memories
  TB Vaccine May Work Against Multiple Sclerosis

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site